L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.
Hanrieder, Jörg
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry. [electronic resource] - Molecular & cellular proteomics : MCP Oct 2011 - M111.009308 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1535-9484
10.1074/mcp.M111.009308 doi
Animals
Antiparkinson Agents--adverse effects
Disease Models, Animal
Dynorphins--analysis
Dyskinesia, Drug-Induced--metabolism
Enkephalins--analysis
Female
Humans
Levodopa--adverse effects
Mice
Neostriatum--metabolism
Parkinson Disease--drug therapy
Protein Precursors--genetics
Rats
Rats, Sprague-Dawley
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry. [electronic resource] - Molecular & cellular proteomics : MCP Oct 2011 - M111.009308 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1535-9484
10.1074/mcp.M111.009308 doi
Animals
Antiparkinson Agents--adverse effects
Disease Models, Animal
Dynorphins--analysis
Dyskinesia, Drug-Induced--metabolism
Enkephalins--analysis
Female
Humans
Levodopa--adverse effects
Mice
Neostriatum--metabolism
Parkinson Disease--drug therapy
Protein Precursors--genetics
Rats
Rats, Sprague-Dawley
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization